ホーム > 市場調査レポート > 医薬品

ワクチン

市場調査レポート

商品コード

1514926

治療用タンパク質および経口ワクチン市場：治療用タンパク質タイプ別、デリバリー方法別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Therapeutic Proteins and Oral Vaccines Market, By Therapeutic Protein Type, By Delivery Method, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日: 2024年06月11日
発行: AnalystView Market Insights
ページ情報: 英文 393 Pages
納期: 2～3営業日

カスタマイズ可能

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

レポートハイライト

治療用タンパク質および経口ワクチンの市場規模は2023年に2億5,145万米ドルとなり、2024年から2032年にかけてCAGR 7.9%で拡大

治療用タンパク質および経口ワクチン市場-市場力学

個別化医療と容易な予防が治療用タンパク質および経口ワクチン市場の成長を牽引

治療用タンパク質および経口ワクチンを用いた個別化医療と手軽な予防戦略が、ヘルスケア市場の活況に拍車をかけています。米国がん学会のデータによると、個別化タンパク質治療であるCAR-T細胞療法は、一部の白血病で80%の寛解率を達成しています。さらに、2023年の世界保健機関（WHO）の報告書によれば、経口ワクチンはその使い勝手の良さから、発展途上国における小児期の予防接種率を20％向上させる可能性があるといいます。このような個別化治療と便利な予防法の融合が、治療用タンパク質および経口ワクチンの分野で多額の投資を促し、市場成長を促進しています。

治療用タンパク質および経口ワクチン市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）においてCAGR約7.9%で年間成長すると予測されています。

治療用タンパク質の種類別セグメントでは、モノクローナル抗体が2023年に最大の市場シェアを示すと予測されています。

デリバリー方法別では、2023年に注射が主要なタイプでした。

地域別では、北米が2023年に収益でリードしました。

治療用タンパク質および経口ワクチン市場-セグメンテーション分析：

世界の治療用タンパク質および経口ワクチン市場は、治療用タンパク質タイプ、デリバリー方法、用途、地域に基づいてセグメント化されます。

市場は治療用タンパク質のタイプに基づいて6つのカテゴリーに分けられます：モノクローナル抗体、酵素、成長因子、インターフェロン、インターロイキン、ワクチン。モノクローナル抗体は、様々ながんや自己免疫疾患を治療するための標的アプローチにより、治療用タンパク質セグメントを支配しています。酵素は代謝性疾患の治療薬として注目されており、成長因子は組織再生に有望視されています。インターフェロンとインターロイキンは免疫調節の可能性を示し、ワクチン、特に経口ワクチンは予防医療に革命をもたらしています。

市場は送達方法によって3つのカテゴリーに分けられる：注射剤、吸入剤、外用剤です。注射は、正確な投与量管理と有効性から、治療用タンパク質の送達方法として依然として主流です。吸入は呼吸器系疾患の治療で普及しつつあり、局所適用は局所治療の利便性を提供します。

治療用タンパク質および経口ワクチン市場-地理的洞察

北米は、高い医療費、慢性疾患の増加、確立された研究インフラなどの要因により、最も高いシェアを占めています。しかし、アジア太平洋のような地域は、可処分所得の増加、政府によるヘルスケアへの取り組み、患者数の多さなどを背景に急成長を遂げています。バイオ医薬品開発に力を入れている欧州は、着実な成長を続ける成熟市場です。アフリカとラテンアメリカの新興諸国は、医療ニーズが満たされておらず、政府のヘルスケアへの投資が拡大しているため、大きな可能性を秘めています。この市場で企業が成功するかどうかは、地域の規制をうまく乗り切り、さまざまな経済環境に対応した価格戦略を展開し、幅広いアクセスを確保するためのパートナーシップを確立できるかどうかにかかっています。

治療用タンパク質および経口ワクチン市場-競合情勢：

治療用タンパク質および経口ワクチン市場は、アムジェン、ファイザー、ジョンソン・エンド・ジョンソンなどの大手製薬企業が覇権を争う競争市場です。これらの企業は、革新的な治療薬や経口ワクチンを開発するために、豊富な研究開発予算を活用しています。合併・買収も戦略的な動きのひとつで、例えばファイザーは鎌状赤血球治療の大手企業を買収しています。さらに、有望なニッチ・ソリューションを持つ中小バイオテクノロジー企業も台頭しており、ダイナミックな環境が醸成されています。研究開発を加速させるためには、これらの企業と学術機関や政府機関との協力が不可欠です。競合情勢は、確立されたタンパク質療法に代わる費用対効果の高い選択肢を提供するバイオシミラーへの注目の高まりによってさらに激化しています。このことは、価格設定にプレッシャーをかけるだけでなく、各社に絶え間ない技術革新と製品の差別化を迫っています。

イントロダクション
北米
- 概要
- 北米の主要メーカー
- 米国
- カナダ
欧州
- 概要
- 欧州の主要メーカー
- ドイツ
- イタリア
- 英国
- フランス
- ロシア
- オランダ
- スウェーデン
- ポーランド
- その他
アジア太平洋（APAC）
- 概要
- アジア太平洋地域の主要メーカー
- インド
- 中国
- 日本
- 韓国
- オーストラリア
- タイ
- インドネシア
- フィリピン
- その他
ラテンアメリカ
- 概要
- ラテンアメリカの主要メーカー
- ブラジル
- メキシコ
- アルゼンチン
- コロンビア
- その他
中東およびアフリカ
- 概要
- 中東・アフリカの主要メーカー
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- トルコ
- アルジェリア
- エジプト
- その他

第11章主要ベンダー分析- 治療用タンパク質および経口ワクチン業界

競争ダッシュボード
企業プロファイル
- Abbott Laboratories
- Amgen Inc.
- Biogen Inc.
- Eli Lilly and Company
- Emergent Biosolutions Inc.
- F. Hoffmann-La Roche Ltd
- Johnson &Johnson
- Lumen Bioscience Inc.
- Merck &Co., Inc.
- MigVax Ltd
- Neurelis Inc.
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi SA
- Serum Institute of India Pvt. Ltd.
- TransAlgae
- Others

第12章アナリストの全方位展望

図表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Therapeutic Proteins and Oral Vaccines Market: Therapeutic Protein Type Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Therapeutic Protein Type
TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type 2019-2032 (USD Million)
TABLE Therapeutic Proteins and Oral Vaccines Market: Delivery Method Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Delivery Method
TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Delivery Method 2019-2032 (USD Million)
TABLE Therapeutic Proteins and Oral Vaccines Market: Application Snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Application 2019-2032 (USD Million)
TABLE Therapeutic Proteins and Oral Vaccines Market: Regional snapshot (2023)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Therapeutic Proteins and Oral Vaccines Market, by Region 2019-2032 (USD Million)
TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
TABLE North America Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
TABLE Europe Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
TABLE Asia Pacific Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
TABLE Latin America Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Therapeutic Protein Type, 2019-2032 (USD Million)
TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Delivery Method, 2019-2032 (USD Million)
TABLE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market, by Application, 2019-2032 (USD Million)

List of Figures

FIGURE Therapeutic Proteins and Oral Vaccines Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2023
FIGURE Therapeutic Protein Type segment market share analysis, 2023 & 2032
FIGURE Therapeutic Protein Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Delivery Method segment market share analysis, 2023 & 2032
FIGURE Delivery Method segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Application segment market share analysis, 2023 & 2032
FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Regional segment market share analysis, 2023 & 2032
FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE North America Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
FIGURE Europe Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
FIGURE Asia Pacific Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
FIGURE Latin America Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
FIGURE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market share and leading players, 2023
FIGURE North America market share analysis by country, 2023
FIGURE U.S. Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Canada Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Europe Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
FIGURE Germany Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Spain Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Italy Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE France Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE UK Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Russia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Netherlands Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Sweden Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Poland Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of the Europe Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Asia Pacific Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
FIGURE India Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE China Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Japan Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE South Korea Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Australia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Thailand Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Indonesia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Philippines Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of APAC Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
FIGURE Brazil Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Mexico Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Argentina Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Colombia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of LATAM Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa Therapeutic Proteins and Oral Vaccines Market share analysis by country, 2023
FIGURE Saudi Arabia Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE United Arab Emirates Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Israel Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Turkey Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Algeria Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Egypt Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of MEA Therapeutic Proteins and Oral Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)

Product Code: ANV2997

REPORT HIGHLIGHT

Therapeutic Proteins and Oral Vaccines Market size was valued at USD 251.45 Million in 2023, expanding at a CAGR of 7.9% from 2024 to 2032.

The Therapeutic Proteins and Oral Vaccines market encompasses treatments utilizing proteins and convenient oral vaccines. This growth is fueled by the rising need for these therapies, particularly in cancer, diabetes, and infectious diseases. Increased clinical trials, advancements in protein engineering, and growing government support for research are propelling the market forward. However, high manufacturing costs and stringent regulatory hurdles pose challenges. Despite these, the potential for personalized medicine using therapeutic proteins and the growing demand for needle-free vaccination present exciting market opportunities.

Therapeutic Proteins and Oral Vaccines Market- Market Dynamics

Personalized Medicine & Easy Prevention Drive Therapeutic Protein & Oral Vaccine Market Growth

Personalized medicine and easy prevention strategies using therapeutic proteins and oral vaccines are fueling a boom in the healthcare market. American Cancer Society data shows CAR-T cell therapy, a personalized protein treatment, achieving an 80% remission rate in some leukemias. Furthermore, a 2023 World Health Organization report suggests oral vaccines could raise childhood immunization rates in developing countries by 20% due to their user-friendliness. This confluence of personalized treatments and convenient preventative methods is driving substantial investment and propelling market growth within the Therapeutic Protein and Oral Vaccine sectors.

Therapeutic Proteins and Oral Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.9% over the forecast period (2024-2032)

Based on Therapeutic Protein Type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2023

Based on Delivery Method segmentation, Injections were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Therapeutic Proteins and Oral Vaccines Market- Segmentation Analysis:

The Global Therapeutic Proteins and Oral Vaccines Market is segmented based on Therapeutic Protein Type, Delivery Method, Application, and Region.

The market is divided into six categories based on Therapeutic Protein Type: Monoclonal Antibodies, Enzymes, Growth Factors, Interferons, Interleukins, and Vaccines. Monoclonal antibodies dominate the therapeutic protein segment due to their targeted approach to treating various cancers and autoimmune diseases. Enzymes are gaining traction for metabolic disorders, while growth factors hold promise in tissue regeneration. Interferons and interleukins show potential in immunomodulation, and vaccines, especially oral ones, are revolutionizing preventative care.

The market is divided into three categories based on Delivery Method: Injection, Inhalation, and Topical application. Injections remain the dominant delivery method for therapeutic proteins due to precise dosage control and effectiveness. Inhalation is gaining traction for respiratory diseases, while topical applications offer convenience for localized treatment.

Therapeutic Proteins and Oral Vaccines Market- Geographical Insights

North America holds the highest share due to factors like high healthcare expenditure, rising chronic disease prevalence, and established research infrastructure. However, regions like Asia Pacific are experiencing rapid growth fueled by increasing disposable income, government healthcare initiatives, and a large patient population. Europe, with its strong focus on biopharmaceutical development, presents a mature market with steady growth. Developing countries in Africa and Latin America offer significant potential due to unmet medical needs and growing government investments in healthcare. The success of companies in this market will depend on their ability to navigate regional regulations, develop pricing strategies that cater to varying economic landscapes, and establish partnerships to ensure wider accessibility.

Therapeutic Proteins and Oral Vaccines Market- Competitive Landscape:

The Therapeutic Proteins and Oral Vaccines market is a competitive arena with established pharmaceutical giants like Amgen, Pfizer, and Johnson & Johnson vying for dominance. These players leverage their extensive R&D budgets to develop innovative therapies and oral vaccines. Mergers and acquisitions are another strategic move, for instance, Pfizer's acquisition of a leading sickle cell therapy company. Additionally, smaller biotechnology firms are emerging with promising niche solutions, fostering a dynamic environment. Collaboration between these players, with academic institutions and government agencies, is crucial for accelerating research and development. The competitive landscape is further intensified by the growing focus on biosimilars, which offer cost-effective alternatives to established protein therapies. This not only puts pressure on pricing but also compels companies to constantly innovate and differentiate their products.

Recent Developments:

In January 2022, Amgen Inc., a biotechnology company, and Generate Biomedicines, a drug generation company, announced a research collaboration agreement to discover and create protein therapeutics for five clinical targets across various disease areas.

In November 2022, Merck & Co., Inc. announced that it would acquire Imago BioSciences, Inc., a clinical-stage biopharmaceutical company developing new medicines for the treatment of myeloproliferative neoplasms, for approximately USD 1.35 billion. Imago's lead candidate, bomedemstat, is an investigational orally available lysine-specific demethylase 1 (LSD1) inhibitor currently being evaluated in multiple Phase 2 clinical trials.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories

Amgen Inc.

Biogen Inc.

Eli Lilly and Company

Emergent Biosolutions Inc.

F. Hoffmann-La Roche Ltd

Johnson & Johnson

Lumen Bioscience Inc.

Merck & Co., Inc.

MigVax Ltd

Neurelis Inc.

Novo Nordisk A/S

Pfizer Inc.

Sanofi S.A.

Serum Institute of India Pvt. Ltd.

TransAlgae

Others

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY THERAPEUTIC PROTEIN TYPE- MARKET ANALYSIS, 2019 - 2032

Monoclonal Antibodies
Enzymes
Growth Factors
Interferons
Interleukins
Vaccines

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

Injection
Inhalation
Topical application

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Cancer
Autoimmune Diseases
Infectious Diseases
Neurological Disorders
Metabolic Disorders
Other Diseases

GLOBAL THERAPEUTIC PROTEINS AND ORAL VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Therapeutic Proteins and Oral Vaccines Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Therapeutic Proteins and Oral Vaccines Market Snippet by Therapeutic Protein Type
- 2.1.2. Therapeutic Proteins and Oral Vaccines Market Snippet by Delivery Method
- 2.1.3. Therapeutic Proteins and Oral Vaccines Market Snippet by Application
- 2.1.4. Therapeutic Proteins and Oral Vaccines Market Snippet by Country
- 2.1.5. Therapeutic Proteins and Oral Vaccines Market Snippet by Region
2.2. Competitive Insights

3. Therapeutic Proteins and Oral Vaccines Key Market Trends

3.1. Therapeutic Proteins and Oral Vaccines Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Therapeutic Proteins and Oral Vaccines Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Therapeutic Proteins and Oral Vaccines Market Opportunities
3.4. Therapeutic Proteins and Oral Vaccines Market Future Trends

4. Therapeutic Proteins and Oral Vaccines Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Therapeutic Proteins and Oral Vaccines Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Therapeutic Proteins and Oral Vaccines Market Landscape

6.1. Therapeutic Proteins and Oral Vaccines Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Therapeutic Proteins and Oral Vaccines Market - By Therapeutic Protein Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Therapeutic Protein Type, 2023 & 2032 (%)
- 7.1.2. Monoclonal Antibodies
- 7.1.3. Enzymes
- 7.1.4. Growth Factors
- 7.1.5. Interferons
- 7.1.6. Interleukins
- 7.1.7. Vaccines

8. Therapeutic Proteins and Oral Vaccines Market - By Delivery Method

8.1. Overview
- 8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
- 8.1.2. Injection
- 8.1.3. Inhalation
- 8.1.4. Topical application

9. Therapeutic Proteins and Oral Vaccines Market - By Application

9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 9.1.2. Cancer
- 9.1.3. Autoimmune Diseases
- 9.1.4. Infectious Diseases
- 9.1.5. Neurological Disorders
- 9.1.6. Metabolic Disorders
- 9.1.7. Other Diseases

10. Therapeutic Proteins and Oral Vaccines Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Therapeutic Proteins and Oral Vaccines Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Therapeutic Protein Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Therapeutic Proteins and Oral Vaccines Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Abbott Laboratories
- 11.2.2. Amgen Inc.
- 11.2.3. Biogen Inc.
- 11.2.4. Eli Lilly and Company
- 11.2.5. Emergent Biosolutions Inc.
- 11.2.6. F. Hoffmann-La Roche Ltd
- 11.2.7. Johnson & Johnson
- 11.2.8. Lumen Bioscience Inc.
- 11.2.9. Merck & Co., Inc.
- 11.2.10. MigVax Ltd
- 11.2.11. Neurelis Inc.
- 11.2.12. Novo Nordisk A/S
- 11.2.13. Pfizer Inc.
- 11.2.14. Sanofi S.A.
- 11.2.15. Serum Institute of India Pvt. Ltd.
- 11.2.16. TransAlgae
- 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

治療用タンパク質および経口ワクチン市場：治療用タンパク質タイプ別、デリバリー方法別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Therapeutic Proteins and Oral Vaccines Market, By Therapeutic Protein Type, By Delivery Method, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

全表示

レポートハイライト

治療用タンパク質および経口ワクチン市場-セグメンテーション分析：

治療用タンパク質および経口ワクチン市場-競合情勢：

目次

第1章 治療用タンパク質および経口ワクチン市場概要

第2章 エグゼクティブサマリー

第3章 治療用タンパク質および経口ワクチンの主要市場動向

第4章 治療用タンパク質および経口ワクチン産業の調査

第5章 治療用タンパク質および経口ワクチン市場： COVID-19の影響分析

第6章 治療用タンパク質および経口ワクチンの市場情勢

第7章 治療用タンパク質および経口ワクチン市場：治療用タンパク質タイプ別

第8章 治療用タンパク質および経口ワクチン市場：デリバリー方法別

第9章 治療用タンパク質および経口ワクチン市場：用途別

第10章 治療用タンパク質および経口ワクチン市場：地域別

第11章 主要ベンダー分析- 治療用タンパク質および経口ワクチン業界

第12章 アナリストの全方位展望